ABSTRACT
Objetivo Conocer la incidencia de síndrome de abstinencia tras perfusión prolongada de fentanilo y midazolam en niños, y los factores de riesgo asociados. Diseño Estudio de cohorte histórica o retrospectiva. Ámbito UCI pediátrica de seis camas de un hospital universitario. Pacientes Se incluyen 48 pacientes pediátricos que recibieron sedoanalgesia en perfusión continua con midazolam y fentanilo exclusivamente, durante al menos 48 horas. Intervenciones Ninguna. Variables de interés principales Se recogen datos clínicos y demográficos, dosis y duración de sedoanalgesia recibida, aparición de síndrome de abstinencia, gravedad y tratamiento del mismo. Resultados El 50% desarrolló síndrome de abstinencia. Hubo diferencias significativas entre los que lo desarrollaron y los que no en cuanto a duración del tratamiento previo y dosis acumulada de ambos fármacos. Una dosis acumulada de fentanilo de 0,48mg/kg o de midazolam de 40mg/kg, y una duración de la perfusión de ambos de 5,75 días fueron factores de riesgo para el desarrollo de abstinencia. La mayoría presentó un cuadro leve o moderado, que comenzó a las 12-36 horas de suspender la perfusión. El fármaco más utilizado en el tratamiento fue la metadona. Conclusiones La incidencia de síndrome de abstinencia en niños tras perfusión prolongada de midazolam y fentanilo es elevada. El desarrollo del síndrome se relaciona con tiempos de perfusión prolongados y con dosis acumuladas elevadas de ambos fármacos (AU)
Objective To determine the incidence of withdrawal syndrome after prolonged infusion of fentanyl and midazolam in children, and the associated risk factors. Design Historic or retrospective cohort study. Setting Pediatric Intensive Care Unit in an academic center. Patients Forty-eight pediatric patients who received sedation and analgesia only with fentanyl and midazolam through continuous infusion for at least 48hours.InterventionsNone.Main variables of interest Collected data included demographic and clinical parameters, dose and duration of sedation received, and incidence, severity and treatment of withdrawal syndrome. Results Fifty percent of the patients developed withdrawal syndrome. There were significant differences between the patients who developed withdrawal syndrome and those who did not, in terms of the duration of infusion and the cumulative doses of both drugs. A cumulative fentanyl dose of 0.48mg/kg, a cumulative midazolam dose of 40mg/kg, and a duration of infusion of both drugs of 5.75 days were risk factors for the development of withdrawal syndrome. Most children developed mild or moderate disease, beginning about 12-36hours after weaning from infusion. Methadone was used in most cases for treating with drawal. Conclusions There is a high incidence of withdrawal syndrome in children following the continuous infusion of midazolam and fentanyl. The duration of infusion of both drugs and higher cumulative doses are associated with the development of withdrawal syndrome (AU)
Subject(s)
Humans , Male , Female , Infant, Newborn , Neonatal Abstinence Syndrome/epidemiology , Fentanyl/adverse effects , Midazolam/adverse effects , Critical Care/methods , Intensive Care Units/statistics & numerical data , Retrospective Studies , Pregnancy Complications/drug therapyABSTRACT
OBJECTIVE: To determine the incidence of withdrawal syndrome after prolonged infusion of fentanyl and midazolam in children, and the associated risk factors. DESIGN: Historic or retrospective cohort study. SETTING: Pediatric Intensive Care Unit in an academic center. PATIENTS: Forty-eight pediatric patients who received sedation and analgesia only with fentanyl and midazolam through continuous infusion for at least 48 hours. INTERVENTIONS: None. MAIN VARIABLES OF INTEREST: Collected data included demographic and clinical parameters, dose and duration of sedation received, and incidence, severity and treatment of withdrawal syndrome. RESULTS: Fifty percent of the patients developed withdrawal syndrome. There were significant differences between the patients who developed withdrawal syndrome and those who did not, in terms of the duration of infusion and the cumulative doses of both drugs. A cumulative fentanyl dose of 0.48 mg/kg, a cumulative midazolam dose of 40 mg/kg, and a duration of infusion of both drugs of 5.75 days were risk factors for the development of withdrawal syndrome. Most children developed mild or moderate disease, beginning about 12-36 hours after weaning from infusion. Methadone was used in most cases for treating withdrawal. CONCLUSIONS: There is a high incidence of withdrawal syndrome in children following the continuous infusion of midazolam and fentanyl. The duration of infusion of both drugs and higher cumulative doses are associated with the development of withdrawal syndrome.
Subject(s)
Analgesics, Opioid/adverse effects , Fentanyl/adverse effects , Hypnotics and Sedatives/adverse effects , Midazolam/adverse effects , Substance Withdrawal Syndrome/epidemiology , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Incidence , Infant , Infant, Newborn , Intensive Care Units, Pediatric , Male , Retrospective Studies , Risk Factors , Time FactorsABSTRACT
Objetivo: Valorar la fiabilidad de la medición de la presión transcutánea de dióxido de carbono (PtCO2) respecto a la medición de la presión arterial de dióxido de carbono (PaCO2). Material y métodos: Estudio analítico, observacional, longitudinal y prospectivo. Cohorte de pacientes ingresados en unidad de cuidados intensivos pediátricos. La PtCO2 se midió con el monitor digital SenTec, aplicando el sensor con un anillo específico (sensor V-sign, versión MDB 04.04.02). Se recogieron al mismo tiempo la PtCO2 y PaCO2. La significación estadística de la asociación se calculó mediante el test F de Snedecor, el coeficiente de correlación r2 de Pearson y el coeficiente de correlación intraclase. El grado de acuerdo se estimó con el método de Bland y Altman. La consistencia de los resultados se estudió con el ANOVA. Resultados: Se compararon 106 mediciones pareadas de PtCO2 y PaCO2, de 12 pacientes. Las PaCO2 y PtCO2 medias fueron 51,0±13mmHg y 50,1±14mmHg; r2=0,87 (p<0,001), CCI=0,96 (IC: 0,940,97). El análisis de Bland-Altman mostró una media de las diferencias de−0,9mmHg (IC:−2,0 a 0,2mmHg). La correlación fue mejor en ausencia de patología respiratoria, con asistencia respiratoria baja, con PaCO2>50mmHg y con aplicación frontal del sensor. Hubo consistencia de los resultados. No se observaron efectos secundarios derivados de la utilización del anillo. Conclusiones: La correlación obtenida entre la PtCO2 y PaCO2 fue muy buena. El monitor digital SenTec y el sensor de anillo específico constituyen una herramienta fiable, segura y fácil de utiliza (AU)
Objective: To estimate the accuracy of the transcutaneous carbon dioxide tension measurement (PtCO2) compared to the measurement of the arterial carbon dioxide tension (PaCO2). Material and methods: An analytical, longitudinal, prospective and observational study, of a dynamic cohort taken from the in-patients of a Paediatric Intensive Care Unit (PICU). The PtCO2 was measured with the SenTec AG analyzer, and the sensor was applied with the specific Multi-Site Attachment Ring. PtCO2 and PaCO2 were recorded at the same time. The statistical significance of the association between paired measurements was evaluated with the Snedecor's F test, the Pearson's r2 correlation coefficient and the Interclass Correlation Coefficient (ICC). The degree of agreement was evaluated with the Bland & Altman method. The consistency of the results was evaluated with the ANalysis Of the VAriance (ANOVA). Results: One hundred and six paired measurements, PtCO2 and PaCO2, from twelve patients, were compared. The means of the PaCO2 and PtCO2 were 51.0±13mmHg and 50.1±14mmHg, respectively; r2=0.87 (p<0.001), ICC=0.96, (95% CI: 0.940.97). The Bland-Altman analysis showed a mean difference of−0.9mmHg (95% CI:−2.0 to 0.2mmHg). The correlation was better in cases with no respiratory disease, with low respiratory assistance, with PaCO2>50mmHg and with the sensor applied on the forehead. The results were consistent. No side effects derived from the use of the ring were observed. Conclusion: The correlation between PtCO2 and PaCO2 is excellent and stable. The ring sensor was safe and easy to us (AU)
Subject(s)
Humans , Male , Female , Child , Critical Care/methods , Critical Care/methods , Partial Pressure , Carbon Dioxide/administration & dosage , Carbon Dioxide/therapeutic use , Monitoring, Physiologic/methods , Drug Monitoring/trends , Signs and Symptoms , Prospective Studies , Longitudinal Studies , Analysis of VarianceABSTRACT
OBJECTIVE: To estimate the accuracy of the transcutaneous carbon dioxide tension measurement (PtCO(2)) compared to the measurement of the arterial carbon dioxide tension (PaCO(2)). MATERIAL AND METHODS: An analytical, longitudinal, prospective and observational study, of a dynamic cohort taken from the in-patients of a Paediatric Intensive Care Unit (PICU). The PtCO(2) was measured with the SenTec AG analyzer, and the sensor was applied with the specific Multi-Site Attachment Ring. PtCO(2) and PaCO(2) were recorded at the same time. The statistical significance of the association between paired measurements was evaluated with the Snedecor's F test, the Pearson's r(2) correlation coefficient and the Interclass Correlation Coefficient (ICC). The degree of agreement was evaluated with the Bland & Altman method. The consistency of the results was evaluated with the ANalysis Of the VAriance (ANOVA). RESULTS: One hundred and six paired measurements, PtCO(2) and PaCO(2), from twelve patients, were compared. The means of the PaCO(2) and PtCO(2) were 51.0+/-13mmHg and 50.1+/-14mmHg, respectively; r(2)=0.87 (p<0.001), ICC=0.96, (95% CI: 0.94-0.97). The Bland-Altman analysis showed a mean difference of-0.9mmHg (95% CI:-2.0 to 0.2mmHg). The correlation was better in cases with no respiratory disease, with low respiratory assistance, with PaCO(2)>50mmHg and with the sensor applied on the forehead. The results were consistent. No side effects derived from the use of the ring were observed. CONCLUSION: The correlation between PtCO(2) and PaCO(2) is excellent and stable. The ring sensor was safe and easy to use.
Subject(s)
Blood Gas Monitoring, Transcutaneous , Critical Illness , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Prospective StudiesSubject(s)
Accidents, Home , Diazinon/poisoning , Insecticides/poisoning , Child , Child, Preschool , Female , Humans , MaleABSTRACT
El maltrato infantil en sus diversas formas de manifestaciónes un problema que afecta a la infancia en el mundo entero y los pediatras, como responsables de la salud integral del niño, debemos estar concienciados de la importancia de intervenir en nuestro entorno para identificar situaciones de riesgo y aprovechar todos los recursos sociosanitarios para la implementación de medidas preventivas adecuadas. Se ha elaborado un protocolo con el fin de facilitarla atención adecuada de estos niños en la provincia de Salamanca (AU)
Child battering in its different manifestation forms is a problem that affects young children worldwide. The pediatricians, who are responsible for the integral health of the child, should be aware of the importance of intervening within their setting in order to identify risk situations and to take advantage of the social-health care resources for the establishment of adequate preventive measures. A protocol has been elaborated in order to facilitate adequate care for these children in the providence of Salamanca (AU)
Subject(s)
Humans , Male , Female , Child , Child Abuse/legislation & jurisprudence , Child Abuse/prevention & control , Child Abuse/statistics & numerical data , Child Abuse, Sexual/diagnosis , Child Abuse, Sexual/legislation & jurisprudence , Child Abuse, Sexual/therapy , Primary Health Care/methods , Risk Factors , Child Abuse/diagnosis , Child Abuse/therapy , Clinical Protocols , 35170/legislation & jurisprudence , 35170/methods , Risk , Child Abuse, Sexual/prevention & control , Child Abuse, Sexual/psychology , Primary Health Care/legislation & jurisprudence , Primary Health Care/trendsABSTRACT
The cases of three female Guinean children are described. Bloods tests were nonspecific, showing a moderately high globular sedimentation rate. The patients received combined therapy with systemic antibiotic therapy (including local gentamicin administration in two of the three patients) and surgery. One patient returned to Guinea and was lost to follow-up. The second patient showed severe sequelae and the third patient had a favorable outcome. In recent years, the prevalence of chronic osteomyelitis in Africa has increased. Most patients have multiple bone involvement and multiple etiology. Blood cultures are negative in 40 % of patients and severe radiologic abnormalities, most commonly fractures, are frequent. A successful therapeutic regimen must be based on antibiotic and surgical treatment.
Subject(s)
Osteomyelitis , Child , Child, Preschool , Chronic Disease , Emigration and Immigration , Female , Guinea/ethnology , Humans , Osteomyelitis/etiology , Osteomyelitis/physiopathology , Osteomyelitis/therapy , Spain/epidemiologyABSTRACT
Se presentan los casos de 3 niñas guineanas con osteomielitis crónica múltiple. Los estudios de laboratorio fueron anodinos con velocidades de sedimentación globular moderadas. Se instauró tratamiento combinando con antibioticoterapia sistémica, local con gentamicina (en los casos 2 y 3) y tratamiento quirúrgico. La primera paciente regresó a su país, por lo que no fue posible su seguimiento; la segunda paciente presenta importantes secuelas, y la tercera evoluciona favorablemente. Se aprecia un aumento de casos de osteomielitis crónica en África; la mayoría presentan afectación de múltiples huesos y están causadas por varios gérmenes. Los cultivos son negativos en el 40 por ciento y los datos del laboratorio son inespecíficos. En los estudios de imagen aparecen signos radiológicos floridos; la fractura es el más frecuente. El éxito de la resolución del cuadro depende de un tratamiento combinado: antibioticoterapia y tratamiento quirúrgico (AU)
Subject(s)
Humans , Female , Child, Preschool , Child , Osteomyelitis , Spain , Emigration and Immigration , Chronic Disease , GuineaABSTRACT
Objetivo: Encontrar los determinantes asociados con elevación de la uremia en los primeros días de vida en prematuros muy inmaduros. Métodos: Estudio prospectivo de una cohorte de recién nacidos con menos de 30 semanas de gestación. Resultados: Se incluyeron 48 prematuros nacidos vivos, de los que 10 fallecieron. Los aportes medios de líquidos fueron 55, 72, 88 y 124 ml/kg en el primer, segundo, tercer y séptimo días de vida. El aporte de aminoácidos en los primeros 2 días fue escaso y no se relacionó con la uremia. El 31 por ciento presentaron hipernatremia. En 31 prematuros se obtuvo la uremia entre el quinto y el décimo día de vida. Se encontraron 12 (38,7 por ciento) con valores de 100 mg/dl o superiores, sin elevación de la creatininemia. Todos ellos tuvieron menos de 27 semanas de gestación, menos de 850 g al nacer, mayor pérdida de peso (19,2 por ciento frente a 13,8 por ciento; p = 0,037) y mayor natremia máxima (150,2 mEq/l frente a 146,6 mEq/l; p = 0,023). El uso de furosemida aumentó el riesgo de uremia elevada (riesgo relativo [RR], 2,54; intervalo de confianza del 95 por ciento [IC 95 por ciento], 1,05-6,14).Conclusiones La uremia total de 100 mg/dl o superior se relacionó con determinantes asociados con excesiva pérdida precoz de agua libre, como mayor pérdida de peso, mayor natremia máxima, uso de furosemida, menor gestación y menor peso al nacer (AU)
Subject(s)
Male , Infant, Newborn , Female , Humans , Uremia , Prospective Studies , Age Factors , Gestational AgeABSTRACT
OBJECTIVE: To identify the determinants associated with uremia elevation in the first days of life in extremely premature infants. METHODS: We performed a prospective cohort study in a cohort of neonates born at less than 30 weeks of gestation. RESULTS: Forty-eight preterm infants were included, of which 10 died. The mean fluid administration was 55, 72, 88 and 124 mL/kg on the first, second, third and seventh days of life. Amino acid doses were low in the first two days of life and were unrelated to uremia elevation. Thirty-one percent of the infants presented hypernatremia. Uremia was measured in 31 infants between the fifth and tenth days of life and 12 infants (38.7 %) had uremia values of 100 mg/dL or higher, without creatinine elevation. All of these infants were born at less than 27 weeks of gestation, weighed less than 850 grams at birth, and showed greater weight loss (19.2 % vs. 13.8 %; p 5 0.037) and higher natremia (150.2 mEq/L vs. 146.6 mEq/L; p 5 0.023). The use of furosemide increased the risk of elevated uremia (relative risk: 2.54; 95 % confidence interval: 1.05 6.14). CONCLUSIONS: Total uremia of 100 mg/dL or higher was associated with dehydration, greater weight loss, higher natremia, furosemide use, lower gestational age, and lower birth weight.
Subject(s)
Uremia/etiology , Age Factors , Female , Gestational Age , Humans , Infant, Newborn , Male , Prospective Studies , Uremia/blood , Uremia/epidemiologyABSTRACT
No disponible
Subject(s)
Adolescent , Male , Infant , Female , Humans , Syndrome , Erythema Infectiosum , Skin Diseases, Papulosquamous , Purpura , BCG Vaccine , Lymphadenitis , Fever , Hand Dermatoses , Foot DermatosesABSTRACT
No disponible
